Trade AstraZeneca AZN

AstraZeneca live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close change Change (%) Open High Low

AstraZeneca news

Frances Wang 2025 Jun 02, 16:00

TEM stock price analysis: Why Tempus AI Stock Up Today?

Stocks
London Uk
Georgy Istigechev 2024 Jan 16, 08:02

FTSE 100 index near one-month lows as global sentiment sours

Shares Indices FTSE100
Moderna Share Price
Georgy Istigechev 2024 Jan 03, 08:01

Moderna share price jumps as Oppenheimer upgrades stock

Shares
Consumer inflation
Neil Wilson 2023 Nov 03, 04:01

Week ahead: RBA poised to hike?

Forex Indices
FTSE 100
Georgy Istigechev 2023 Sep 26, 10:00

FTSE 100 Index: London stocks start week sharply lower

Indices

Latest news

Show more
Noah Lee 2025 Aug 07, 15:20

Waller Emerges as Potential Fed Chair Nominee Amidst Trump Considerations

Emma Rose 2025 Aug 07, 14:20

US Jobless Claims Rise: Analyzing Labor Market Trends and Economic Impact

Noah Lee 2025 Aug 07, 13:20

Trump-Putin Talks Fuel Ukraine Asset Rally Amid Peace Hope

Noah Lee 2025 Aug 07, 11:20

Netanyahu Seeks Approval for Full Israeli Occupation of Gaza: Implications and Analysis

Noah Lee 2025 Aug 07, 09:20

The Dollar Squeeze: How Rate Cuts Impact International Investors

Sophia Claire 2025 Aug 07, 09:20

Putin and Trump Meeting Possible Next Week Amid Ukraine Tensions: Kremlin

Noah Lee 2025 Aug 07, 06:20

Bank of England Expected to Cut Rates Amid Inflation Concerns and Slowing Growth

Ava Grace 2025 Aug 07, 05:20

Israel Gaza Conflict: Is a New Offensive on the Horizon?

Info

Spread

67.78

Spread (%)

0.6202 %

Leverage

1:10

Overnight Interest Buy

-0.0590 %

Overnight Interest Sell

-0.0299 %

Currency

PNC

Trading Hours

Markets closed

Friday

07:01 - 10:59

Monday

07:01-10:59

Monday

11:03-15:29

Tuesday

07:01-10:59

Tuesday

11:03-15:29

Wednesday

07:01-10:59

Wednesday

11:03-15:29

Thursday

07:01-10:59

Thursday

11:03-15:29

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

171363532800

Shares Outstanding

1550240000

Earnings Date (Next)

0000-00-00

instr__dividend_date

instr__ex_dividend_date

2025-08-07

instr__forward_annual_dividend_rate

2.45

instr__forward_annual_dividend_yield

0.0218

EPS

3.99

Learn more about this instrument

AstraZeneca AstraZeneca PLC
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Crestor, Seloken, Lokelma, Roxadustat, Andexxa, Wainua, Symbicort, Fasenra, Pulmicort, Breztri/Trixeo, Saphnelo, Tezspire, Airsupra, Ultomiris, Soliris, Strensiq, Koselugo, Kanuma, Atacand, Plendil, Modip, Splendil, Munobal, Flodil, Komboglyze, Qtern, Byetta, XIGDUO, Accolate, Accoleit, Vanticon, Beyfortus, Synagis, FluMist, tixagevimab and cilgavimab, and sipavibart. It also provides Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Bricanyl Turbuhaler, Rhinocort, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Breztri Aerosphere, Duaklir Genuair, Kavigale, Evusheld, Fluenz/FluMist, and Voydeya. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the United States, Europe, and Asia. It has a strategic agreement with Tempus to develop the largest multimodal foundation model in oncology. The company has a collaboration agreement with IonQ, Inc. for the development of quantum-accelerated computational chemistry workflow for healthcare, life sciences, and chemistry; a strategic research collaboration with CSPC Pharmaceutical Group Limited to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications; and collaboration Revna Biosciences for lung cancer treatment. AstraZeneca PLC was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Trustpilot